Literature DB >> 27662365

TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.

Giacomo Lettini1, Lorenza Sisinni1, Valentina Condelli1, Danilo Swann Matassa2, Vittorio Simeon1, Francesca Maddalena1, Marica Gemei3, Elvira Lopes1, Giulia Vita4, Luigi Del Vecchio3, Franca Esposito2, Matteo Landriscina1,5.   

Abstract

Colorectal carcinoma (CRC) is a common cause of cancer-related death worldwide. Indeed, treatment failures are triggered by cancer stem cells (CSCs) that give rise to tumor repopulation upon initial remission. Thus, the role of the heat shock protein TRAP1 in stemness was investigated in CRC cell lines and human specimens, based on its involvement in colorectal carcinogenesis, through regulation of apoptosis, protein homeostasis and bioenergetics. Strikingly, co-expression between TRAP1 and stem cell markers was observed in stem cells located at the bottom of intestinal crypts and in CSCs sorted from CRC cell lines. Noteworthy, TRAP1 knockdown reduced the expression of stem cell markers and impaired colony formation, being the CSC phenotype and the anchorage-independent growth conserved in TRAP1-rich cancer cells. Consistently, the gene expression profiling of HCT116 cells showed that TRAP1 silencing results in the loss of the stem-like signature with acquisition of a more-differentiated phenotype and the downregulation of genes encoding for activating ligands and target proteins of Wnt/β-catenin pathway. Mechanistically, TRAP1 maintenance of stemness is mediated by the regulation of Wnt/β-catenin signaling, through the modulation of the expression of frizzled receptor ligands and the control of β-catenin ubiquitination/phosphorylation. Remarkably, TRAP1 is associated with higher expression of β-catenin and several Wnt/β-catenin target genes in human CRCs, thus supporting the relevance of TRAP1 regulation of β-catenin in human pathology. This study is the first demonstration that TRAP1 regulates stemness and Wnt/β-catenin pathway in CRC and provides novel landmarks in cancer biology and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27662365      PMCID: PMC5071570          DOI: 10.1038/cdd.2016.67

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.

Authors:  Markus D Siegelin; Takehiko Dohi; Christopher M Raskett; Gregory M Orlowski; Christine M Powers; Candace A Gilbert; Alonzo H Ross; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

Review 2.  Cancer stem cells: an evolving concept.

Authors:  Long V Nguyen; Robert Vanner; Peter Dirks; Connie J Eaves
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

3.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

4.  TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.

Authors:  Lorenza Sisinni; Francesca Maddalena; Giacomo Lettini; Valentina Condelli; Danilo Swann Matassa; Franca Esposito; Matteo Landriscina
Journal:  Int J Oncol       Date:  2013-11-29       Impact factor: 5.650

5.  Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis.

Authors:  N Montesano Gesualdi; G Chirico; G Pirozzi; E Costantino; M Landriscina; F Esposito
Journal:  Stress       Date:  2007-11       Impact factor: 3.493

6.  Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.

Authors:  Francesca Maddalena; Lorenza Sisinni; Giacomo Lettini; Valentina Condelli; Danilo Swann Matassa; Annamaria Piscazzi; Maria Rosaria Amoroso; Giuseppe La Torre; Franca Esposito; Matteo Landriscina
Journal:  Mol Oncol       Date:  2013-05-02       Impact factor: 6.603

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.

Authors:  Elmer Hoekstra; Liudmila L Kodach; Asha M Das; Roberta R Ruela-de-Sousa; Carmen V Ferreira; James C Hardwick; C Janneke van der Woude; Maikel P Peppelenbosch; Timo L M Ten Hagen; Gwenny M Fuhler
Journal:  Oncotarget       Date:  2015-04-10

9.  Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil.

Authors:  Jae Joon Han; Sun Kyung Baek; Jae Jin Lee; Gou Young Kim; Si-Young Kim; Suk-Hwan Lee
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

10.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.

Authors:  Oksana Voloshanenko; Gerrit Erdmann; Taronish D Dubash; Iris Augustin; Marie Metzig; Giusi Moffa; Christian Hundsrucker; Grainne Kerr; Thomas Sandmann; Benedikt Anchang; Kubilay Demir; Christina Boehm; Svenja Leible; Claudia R Ball; Hanno Glimm; Rainer Spang; Michael Boutros
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  21 in total

Review 1.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

2.  Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.

Authors:  Michele Pietrafesa; Francesca Maddalena; Luciana Possidente; Valentina Condelli; Pietro Zoppoli; Valeria Li Bergolis; Maria Grazia Rodriquenz; Michele Aieta; Giulia Vita; Franca Esposito; Matteo Landriscina
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

3.  Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?

Authors:  Giacomo Lettini; Silvia Lepore; Fabiana Crispo; Lorenza Sisinni; Franca Esposito; Matteo Landriscina
Journal:  Histol Histopathol       Date:  2019-07-19       Impact factor: 2.303

Review 4.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 5.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 6.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 7.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

8.  YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.

Authors:  Zhaoji Pan; Yiqing Tian; Bin Zhang; Xu Zhang; Hui Shi; Zhaofeng Liang; Peipei Wu; Rong Li; Benshuai You; Lunyu Yang; Fei Mao; Hui Qian; Wenrong Xu
Journal:  Int J Oncol       Date:  2017-08-23       Impact factor: 5.650

9.  Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway.

Authors:  Hong-Fang Yang; Ming Yu; Hui-Dan Jin; Jia-Qi Yao; Zhi-Li Lu; Iddrisu B Yabasin; Qiu Yan; Qing-Ping Wen
Journal:  Front Physiol       Date:  2017-07-26       Impact factor: 4.566

10.  FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells.

Authors:  Shuo Liu; Cun Zhang; Kuo Zhang; Yuan Gao; Zhaowei Wang; Xiaoju Li; Guang Cheng; Shuning Wang; Xiaochang Xue; Weina Li; Wei Zhang; Yingqi Zhang; Xianghui Xing; Meng Li; Qiang Hao
Journal:  Oncotarget       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.